Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial)
- PMID: 17617892
- PMCID: PMC1934382
- DOI: 10.1186/1471-2393-7-11
Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial)
Abstract
Background: Preterm prelabour rupture of the membranes (PPROM) is an important clinical problem and a dilemma for the gynaecologist. On the one hand, awaiting spontaneous labour increases the probability of infectious disease for both mother and child, whereas on the other hand induction of labour leads to preterm birth with an increase in neonatal morbidity (e.g., respiratory distress syndrome (RDS)) and a possible rise in the number of instrumental deliveries.
Methods/design: We aim to determine the effectiveness and cost-effectiveness of immediate delivery after PPROM in near term gestation compared to expectant management. Pregnant women with preterm prelabour rupture of the membranes at a gestational age from 34+0 weeks until 37+0 weeks will be included in a multicentre prospective randomised controlled trial. We will compare early delivery with expectant monitoring. The primary outcome of this study is neonatal sepsis. Secondary outcome measures are maternal morbidity (chorioamnionitis, puerperal sepsis) and neonatal disease, instrumental delivery rate, maternal quality of life, maternal preferences and costs. We anticipate that a reduction of neonatal infection from 7.5% to 2.5% after induction will outweigh an increase in RDS and additional costs due to admission of the child due to prematurity. Under these assumptions, we aim to randomly allocate 520 women to two groups of 260 women each. Analysis will be by intention to treat. Additionally a cost-effectiveness analysis will be performed to evaluate if the cost related to early delivery will outweigh those of expectant management. Long term outcomes will be evaluated using modelling.
Discussion: This trial will provide evidence as to whether induction of labour after preterm prelabour rupture of membranes is an effective and cost-effective strategy to reduce the risk of neonatal sepsis. CONTROLLED CLINICAL TRIAL REGISTER: ISRCTN29313500.
Similar articles
-
Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial).Acta Obstet Gynecol Scand. 2014 Apr;93(4):374-81. doi: 10.1111/aogs.12329. Epub 2014 Jan 29. Acta Obstet Gynecol Scand. 2014. PMID: 24392746
-
An economic evaluation of planned immediate versus delayed birth for preterm prelabour rupture of membranes: findings from the PPROMT randomised controlled trial.BJOG. 2017 Mar;124(4):623-630. doi: 10.1111/1471-0528.14302. Epub 2016 Oct 21. BJOG. 2017. PMID: 27770483 Clinical Trial.
-
Child outcomes after induction of labour or expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks of gestation: study protocol of the PPROMEXIL Follow-up trial. A long-term follow-up study of the randomised controlled trials PPROMEXIL and PPROMEXIL-2.BMJ Open. 2021 Jun 15;11(6):e046046. doi: 10.1136/bmjopen-2020-046046. BMJ Open. 2021. PMID: 34130959 Free PMC article.
-
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity.Cochrane Database Syst Rev. 2015 Jan 26;1:CD002250. doi: 10.1002/14651858.CD002250.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2015 Jun 20;(6):CD002250. doi: 10.1002/14651858.CD002250.pub3. PMID: 25621770 Updated. Review.
-
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005302. doi: 10.1002/14651858.CD005302.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2017 Jan 04;1:CD005302. doi: 10.1002/14651858.CD005302.pub3. PMID: 16437525 Updated. Review.
Cited by
-
A systematic scoping review of clinical indications for induction of labour.PLoS One. 2020 Jan 29;15(1):e0228196. doi: 10.1371/journal.pone.0228196. eCollection 2020. PLoS One. 2020. PMID: 31995603 Free PMC article.
-
A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.J Matern Fetal Neonatal Med. 2016 Mar;29(5):707-20. doi: 10.3109/14767058.2015.1020293. Epub 2015 Sep 16. J Matern Fetal Neonatal Med. 2016. PMID: 26373262 Free PMC article.
-
Diagnosis and management of clinical chorioamnionitis.Clin Perinatol. 2010 Jun;37(2):339-54. doi: 10.1016/j.clp.2010.02.003. Clin Perinatol. 2010. PMID: 20569811 Free PMC article. Review.
-
Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial.PLoS Med. 2012;9(4):e1001208. doi: 10.1371/journal.pmed.1001208. Epub 2012 Apr 24. PLoS Med. 2012. PMID: 22545024 Free PMC article. Clinical Trial.
-
Accounting for multiple births in neonatal and perinatal trials: systematic review and case study.J Pediatr. 2010 Feb;156(2):202-8. doi: 10.1016/j.jpeds.2009.08.049. Epub 2009 Dec 6. J Pediatr. 2010. PMID: 19969305 Free PMC article. Review.
References
-
- Lieman JM, Brumfield CG, Carlo W. Preterm premature rupture of membranes: Is there an optimal gestational age for delivery? Obstet Gynecol. 2005;105:12–17. - PubMed
-
- NVOG richtlijn no. 46; Het breken van de vliezen voor het begin van de baring; juni. 2002.
-
- American College of Obstetricians and Gynecologists . ACOG Practice Bullitin 1. Washington DC: ACOG; 1998. Premature rupture of membranes.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources